APDN Rentabilitas dodolan miturut bathi reged Applied DNA Sciences Inc

Applied DNA Sciences (APDN) gross margin history correlates with the implementation of ESG standards and the minimization of chemical waste, with the current level standing at 29.50. The high scalability of molecular tagging across various industries facilitates expansion. Business stability is supported by the transition to contract PCR production for gene therapy, which reduces reliance on volatile safety tests.
Rincian analitis lan laporan data perusahaan Applied DNA Sciences, Inc. (APDN)

The metric is calculated as the difference between total revenue and direct costs, reflecting the efficiency of cost-of-sales management and pricing power. A high indicator value confirms the business's ability to generate profit at the basic production level. Stable utilization of DNA synthesis laboratories and the optimization of PCR systems directly determine the gross margin trajectory, demonstrating the operational resilience of Applied DNA Sciences (APDN).